Medical researchers, engineers look to nanovaccines to fight pancreatic cancer
A research team led by Iowa State’s Balaji Narasimhan, Distinguished Professor of chemical and biological engineering, and affiliated with the Nanovcaccine Institute based at Iowa State is studying nanovaccines for treating pancreatic cancer. There are no screening tests or early warning signs for the disease and so the cancer has often spread when it is found. When that’s the case, current treatments are rarely effective. The researchers say nanovaccines could generate a response in pancreatic cancer. Their study is supported by a $2.67 million grant from the National Cancer Institute of the National Institutes of Health.